7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-03-31 2024-12-31 2024-09-30 2024-03-31 2023-12-31 2023-09-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2014-06-30 2013-03-31 2012-12-31 2012-09-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2009-06-30 2009-03-31 
      
    		                                 
      cash flows from operating activities:
    		                                 
      net earnings
    		1,013,000,000 1,249,500,000 963,200,000 956,300,000 1,184,900,000 878,400,000 859,400,000 1,043,100,000 813,200,000 779,000,000 625,500,000 928,500,000 694,400,000 700,500,000 538,200,000 810,700,000 647,500,000 602,100,000  337,100,000 482,700,000 390,800,000 305,300,000 452,400,000 375,000,000 302,700,000 241,800,000 423,800,000 310,100,000 278,500,000 207,900,000 352,600,000 402,700,000 
      adjustments to reconcile net earnings to cash flows from operating activities:
    		                                 
      depreciation and amortization
    		146,700,000 147,000,000 151,100,000 138,600,000 144,600,000 140,100,000 141,500,000 137,000,000 136,800,000 135,100,000 130,500,000 129,000,000 126,500,000 129,100,000 126,000,000 126,900,000 126,700,000 131,100,000  99,500,000 81,100,000 77,300,000 78,300,000 81,100,000 79,200,000 79,700,000 79,000,000 81,000,000 82,700,000 75,500,000 76,400,000 79,300,000 77,600,000 
      amortization of deferred contract costs
    		298,600,000 286,100,000 284,500,000 281,400,000 268,300,000 264,400,000 262,300,000 249,500,000 245,100,000 243,500,000 240,900,000 239,400,000 237,600,000 237,300,000 234,800,000 235,600,000 232,600,000 232,300,000                
      deferred income taxes
    		64,800,000 -15,300,000 -10,200,000 42,700,000 -26,900,000 -4,300,000 26,800,000 -27,500,000 -10,600,000 20,500,000 34,500,000 -44,300,000 20,800,000 25,600,000 -212,800,000 -39,600,000 -22,200,000 23,500,000  -53,700,000 800,000 -4,500,000 7,100,000 700,000 -2,500,000 9,700,000 55,800,000 34,600,000 9,600,000 7,600,000 45,300,000 -18,800,000 23,300,000 
      stock-based compensation expense
    		58,700,000 62,800,000 79,100,000 60,600,000 56,300,000 73,600,000 58,800,000 67,600,000 58,400,000 50,600,000 55,500,000 48,300,000 55,600,000 42,300,000 48,900,000 45,500,000 47,100,000 33,800,000  74,100,000 22,400,000 24,300,000 17,600,000 20,400,000 27,100,000 18,600,000 17,800,000 21,800,000 22,800,000 13,900,000 12,600,000 10,500,000 22,900,000 
      bad debt expense
    		10,300,000 17,100,000 11,900,000 11,200,000                              
      net pension income
    		-3,800,000 -5,000,000 -4,900,000 -4,900,000 -5,800,000 -5,800,000 -5,800,000 -10,700,000 -10,700,000 -9,300,000  -15,800,000 -15,800,000 -15,800,000  -13,900,000 -10,900,000 -11,100,000                
      net accretion of discounts and amortization of premiums on available-for-sale securities
    		-22,500,000 -18,300,000 -16,000,000 -15,500,000 -11,800,000 -11,900,000 -5,500,000                           
      other
    		2,500,000 6,100,000 3,800,000 900,000 -22,300,000 14,200,000 2,700,000 17,800,000 20,200,000 10,600,000 37,300,000 -11,400,000 3,600,000 3,200,000 17,000,000 15,800,000 -3,700,000 6,100,000  -42,800,000 7,500,000 4,000,000 9,700,000 16,800,000 -3,100,000 4,300,000 2,600,000 -1,100,000 20,800,000 12,800,000 -800,000 39,400,000 900,000 
      changes in operating assets and liabilities:
    		                                 
      decrease in accounts receivable
    		102,000,000                        -103,900,000 106,300,000    27,400,000    
      increase in deferred contract costs
    		-271,400,000 -325,500,000 -295,500,000 -269,800,000 -327,900,000 -276,100,000 -261,900,000                           
      increase in other assets
    		-342,400,000 116,100,000 -53,900,000 -217,100,000 87,900,000 -8,700,000 -304,900,000 -197,800,000 -283,900,000 -504,000,000 -321,500,000 -268,300,000 -174,400,000 -494,200,000 -235,400,000 -150,700,000 -188,500,000 -454,800,000  60,500,000 14,500,000 2,300,000 -330,500,000 -15,900,000 -5,400,000 -117,700,000    -106,300,000   -2,100,000 
      (decrease)/increase in accounts payable
    		-38,000,000          24,900,000 -21,400,000 42,000,000 -61,900,000                    
      decrease in accrued expenses and other liabilities
    		-376,200,000  212,900,000 -323,400,000  231,500,000 -308,600,000  116,000,000 -194,700,000   50,500,000 -413,800,000   -135,800,000 -23,100,000     -73,000,000   -78,800,000  134,300,000 -92,300,000 -68,600,000    
      net cash flows from operating activities
    		642,300,000 1,525,800,000 1,150,300,000 824,400,000 1,498,100,000 1,032,400,000 326,500,000 1,404,100,000 899,700,000 718,100,000 912,900,000 971,000,000 1,093,700,000 121,900,000 652,800,000 1,252,200,000 706,400,000 481,900,000  819,700,000 618,300,000   663,200,000 431,600,000 316,300,000 485,500,000 573,000,000 425,000,000 222,300,000 395,500,000 427,500,000 453,500,000 
      cash flows from investing activities:
    		                                 
      purchases of corporate and client funds marketable securities
    		-3,604,600,000 -1,665,700,000 -1,219,000,000 -2,771,700,000 -3,060,200,000 -595,300,000 -710,200,000 -1,764,000,000 -642,600,000 -3,064,500,000 -1,789,200,000 -3,720,700,000 -2,810,700,000 -2,412,600,000 -2,118,000,000 -3,593,500,000 -2,742,000,000 -812,800,000  422,700,000 -1,677,200,000 -1,394,900,000 -765,500,000 -1,417,100,000 -1,138,000,000 -1,095,100,000 -1,149,600,000 -1,053,600,000 -1,482,400,000 -1,085,300,000 -1,161,400,000 -480,500,000 -520,400,000 
      proceeds from the sales and maturities of corporate and client funds marketable securities
    		1,896,000,000 1,258,800,000 1,257,300,000 1,266,800,000 2,121,400,000 871,200,000 632,000,000 1,355,800,000 907,000,000 1,618,600,000 882,800,000 1,370,000,000 717,800,000 1,279,100,000 1,078,800,000 2,327,100,000 1,635,800,000 1,196,700,000  -802,000,000 1,024,300,000 1,234,700,000 602,500,000 852,100,000   989,200,000 756,500,000 732,500,000 826,900,000 814,000,000 1,068,700,000 755,300,000 
      capital expenditures
    		-46,700,000 -36,400,000 -39,400,000 -58,800,000 -59,600,000 -54,800,000 -39,300,000 -50,300,000 -49,700,000 -45,400,000 -47,600,000 -51,000,000 -39,900,000 -35,900,000 -33,300,000 -64,300,000 -37,500,000 -43,500,000  -94,300,000 -47,000,000 -44,800,000 -30,500,000 -37,800,000 -33,200,000 -33,400,000 -59,800,000 -41,400,000 -42,100,000 -38,600,000 -26,400,000 -45,500,000 -28,800,000 
      free cash flows
    		595,600,000 1,489,400,000 1,110,900,000 765,600,000 1,438,500,000 977,600,000 287,200,000 1,353,800,000 850,000,000 672,700,000 865,300,000 920,000,000 1,053,800,000 86,000,000 619,500,000 1,187,900,000 668,900,000 438,400,000  725,400,000 571,300,000   625,400,000 398,400,000 282,900,000 425,700,000 531,600,000 382,900,000 183,700,000 369,100,000 382,000,000 424,700,000 
      additions to intangibles
    		-94,100,000 -101,100,000 -94,800,000 -80,900,000 -97,500,000 -78,700,000 -87,000,000 -106,900,000 -92,100,000 -86,300,000 -96,700,000 -101,600,000 -87,500,000 -93,200,000 -87,100,000 -92,100,000 -71,700,000 -76,400,000  -69,700,000 -22,400,000 -25,500,000 -33,500,000 -31,100,000 -27,400,000 -24,000,000 -36,900,000 -23,100,000 -16,400,000 -19,400,000 -36,300,000 -32,200,000 -27,900,000 
      acquisitions of businesses, net of cash acquired
    		500,000 -4,500,000   0 0 -33,600,000 -18,000,000   0 0        -10,400,000 -14,600,000 0 -700,000 -23,500,000 -174,400,000 -1,900,000 -1,300,000 -185,900,000 -113,500,000 -475,300,000 -1,100,000 -40,600,000 -19,200,000 
      proceeds from the sale of property, plant, and equipment and other assets
    		                   -9,600,000 0             
      net cash flows used in investing activities
    		-1,862,600,000 -555,900,000 -1,257,900,000 -1,644,400,000 -1,094,000,000 138,300,000 -216,100,000 -583,400,000 108,200,000 -1,577,600,000  -2,495,300,000               7,294,200,000 -8,496,700,000     4,077,800,000 
      cash flows from financing activities:
    		                                 
      net increase/(decrease) in client funds obligations
    		573,100,000    5,577,700,000             3,203,300,000                
      net cash distributed from the internal revenue service
    		-11,500,000  -151,200,000 -336,400,000                              
      payments of debt
    		-300,000 -300,000 -300,000 -300,000 -200,000 -300,000 -200,000 -200,000 -300,000 -200,000 -200,000 -200,000 -300,000 -200,000 -200,000 -500,000 -500,000 -1,000,600,000  13,700,000 -8,300,000 -500,000 -8,200,000 -500,000 -500,000 -500,000 -400,000 -600,000 -400,000 -4,300,000 -1,600,000 -400,000 -8,100,000 
      proceeds from the issuance of debt
    		 0 0 988,900,000           990,400,000 0 0 991,100,000                
      settlement of cash flow hedges
    		 0 0 -12,500,000           -1,000,000 0 0 -43,600,000                
      repurchases of common stock
    		-366,000,000 -311,600,000 -272,300,000 -372,600,000 -291,500,000 -254,700,000 -250,000,000 -264,000,000 -220,200,000 -333,300,000 -487,500,000 -491,400,000 -462,500,000 -528,000,000 -469,800,000 -427,400,000 -261,500,000 -213,600,000  -265,300,000 -95,100,000 -112,400,000 -194,500,000 -102,000,000 -48,700,000 -249,200,000 -558,000,000 -72,700,000 -52,300,000 -49,800,000 -487,200,000 0 -129,200,000 
      net (repurchases)/proceeds from stock-based compensation plans and stock purchase plan
    		-57,800,000                                 
      dividends paid
    		-626,700,000 -628,000,000 -572,500,000 -572,600,000 -575,900,000 -516,300,000 -515,800,000 -520,600,000 -432,600,000 -432,900,000 -434,300,000 -437,700,000 -393,800,000 -393,200,000 -396,000,000 -397,800,000 -390,700,000 -391,000,000  -288,400,000 -210,400,000 -192,200,000 -192,100,000 -192,500,000 -176,200,000 -177,700,000 -179,200,000 -177,600,000 -167,600,000 -168,000,000 -175,300,000 -165,500,000 -166,700,000 
      net proceeds related to reverse repurchase agreements
    		214,800,000 -1,500,000 -641,800,000 297,100,000   273,800,000   54,800,000                        
      net proceeds from issuance of commercial paper
    		438,500,000                                 
      net cash flows provided by/(used in) financing activities
    		164,100,000    5,867,700,000          -6,486,200,000   2,524,100,000                
      effect of exchange rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents
    		-6,700,000 24,000,000 -53,700,000 17,000,000 -26,300,000 26,900,000 -16,300,000 -700,000 20,300,000 -44,900,000 -84,500,000 6,700,000 300,000 -21,200,000 3,400,000 -14,300,000 46,800,000 37,900,000 6,900,000               
      net change in cash, cash equivalents, restricted cash, and restricted cash equivalents
    		-1,062,900,000 -8,405,000,000 13,812,700,000 -7,294,500,000 6,245,500,000 6,917,400,000 -1,809,600,000 4,758,100,000 7,706,500,000 -17,207,000,000 -8,947,600,000 11,196,400,000 -2,658,100,000 10,049,100,000 -6,978,600,000 3,993,300,000 5,766,800,000 3,308,100,000 -1,465,400,000               
      cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period
    		5,054,600,000 0 0 10,086,000,000 0 0 8,771,500,000 0 0 22,783,000,000  0 0 13,143,200,000  0 0 7,053,600,000                
      cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period
    		3,991,700,000 -8,405,000,000 13,812,700,000 2,791,500,000 6,245,500,000 6,917,400,000 6,961,900,000 4,758,100,000 7,706,500,000 5,576,000,000  11,196,400,000 -2,658,100,000 23,192,300,000  3,993,300,000 5,766,800,000 10,361,700,000                
      reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents to the consolidated balance sheets
    		                                 
      cash and cash equivalents
    		2,478,000,000 464,200,000 111,500,000 2,104,900,000 1,650,400,000 199,900,000 1,441,400,000 483,400,000 137,300,000 1,207,700,000 -197,900,000 -110,800,000 142,900,000 1,602,100,000 683,700,000 289,300,000 -10,900,000 1,613,100,000                
      restricted cash and restricted cash equivalents included in funds held for clients
    		1,513,700,000 -8,869,200,000 13,701,200,000 686,600,000 4,595,100,000 6,717,500,000 5,520,500,000 4,274,700,000 7,569,200,000 4,368,300,000 -8,749,700,000 11,307,200,000 -2,801,000,000 21,590,200,000 -7,662,300,000 3,704,000,000 5,777,700,000 8,748,600,000                
      total cash, cash equivalents, restricted cash, and restricted cash equivalents
    		3,991,700,000 -8,405,000,000 13,812,700,000 2,791,500,000 6,245,500,000 6,917,400,000 6,961,900,000 4,758,100,000 7,706,500,000 5,576,000,000 -8,947,600,000 11,196,400,000 -2,658,100,000 23,192,300,000 -6,978,600,000 3,993,300,000 5,766,800,000 10,361,700,000                
      supplemental disclosures of cash flow information:
    		                                 
      cash paid for interest
    		130,300,000 90,400,000 108,800,000 140,700,000 68,100,000 95,800,000 97,000,000 44,000,000 47,800,000 56,700,000 17,700,000 24,000,000 9,200,000 23,900,000 800,000 24,200,000 800,000 27,300,000                
      cash paid for income taxes, net of income tax refunds
    		73,800,000 253,400,000 518,800,000 64,700,000 215,700,000 502,500,000 87,900,000 241,700,000 479,600,000 57,500,000 268,900,000 222,200,000 310,700,000 55,000,000 403,600,000 207,400,000 317,300,000 45,400,000                
      increase in accounts receivable
    		 -44,000,000         47,100,000 -507,600,000 25,800,000 -51,800,000 25,400,000 -278,700,000 -7,800,000 -78,700,000  140,200,000           -17,200,000 -3,600,000 67,700,000 
      increase/(decrease) in accounts payable
    		 -40,400,000 34,400,000 48,000,000           27,100,000   5,700,000                
      increase/(decrease) in accrued expenses and other liabilities
    		              73,800,000         100,900,000          
      proceeds from sale of property, plant, and equipment and other assets
    		 0 0 3,300,000 1,900,000 4,400,000 22,000,000     8,000,000 0 26,200,000  6,000,000 1,600,000 200,000                
      net increase in client funds obligations
    		 -8,456,000,000          13,612,900,000 -684,800,000 12,100,600,000  4,963,500,000          -5,936,900,000 -7,392,700,000 8,239,500,000 1,805,000,000 3,639,100,000 -7,779,300,000 -5,127,700,000 -4,146,600,000 
      net cash (distributed)/received from the internal revenue service
    		                                 
      net proceeds from stock purchase plan and stock-based compensation plans
    		 60,100,000 26,600,000 12,000,000 42,100,000 19,100,000 -36,600,000 47,900,000 23,800,000 1,000,000 23,000,000 23,100,000 67,100,000 -16,700,000 30,600,000 34,400,000 47,000,000 -7,900,000                
      net cash flows (used in)/provided by financing activities
    		       3,938,100,000 6,678,300,000 -16,302,600,000                        
      net cash flows from financing activities
    		           12,714,000,000 -1,520,100,000 11,184,800,000       6,426,700,000   6,243,500,000 3,975,600,000 -6,315,400,000 -7,996,600,000 8,205,500,000 1,691,500,000 3,438,800,000  -4,554,500,000 -4,474,600,000 
      (increase)/decrease in accounts receivable
    		   115,400,000   -107,900,000               -137,300,000 -73,400,000           
      net decrease in client funds obligations
    		   -10,870,500,000   -1,374,900,000                -1,220,400,000           
      net proceeds of commercial paper borrowings
    		   4,375,400,000                              
      net cash flows used in financing activities
    		   -6,491,500,000   -1,903,700,000                -1,093,300,000           
      decrease in accounts payable
    		    9,900,000 11,400,000 -30,400,000 -11,100,000 10,200,000 -30,700,000           12,400,000 2,300,000 -31,400,000 2,400,000 10,300,000 -26,500,000  15,900,000 -22,100,000 -36,600,000   -5,800,000 
      net cash received from the internal revenue service
    		                                 
      net payments related to reverse repurchase agreements
    		    -16,500,000   -9,500,000    0    0                  
      net amortization of premiums and accretion of discounts on available-for-sale securities
    		       1,900,000 7,600,000 16,000,000 24,900,000 27,600,000 25,800,000 22,700,000 20,800,000 20,000,000 16,300,000 12,400,000  36,600,000 19,900,000 19,200,000 18,700,000 15,900,000   12,800,000 13,700,000 14,100,000 13,000,000 13,700,000 14,800,000 14,600,000 
      decrease/(increase) in accounts receivable
    		         201,500,000                        
      (decrease)/increase in accrued expenses and other liabilities
    		                                 
      net (decrease)/increase in client funds obligations
    		       4,684,500,000 7,495,200,000 -15,592,000,000                        
      net pension (income)/expense
    		                                 
      net cash flows (used in)/provided by investing activities
    		             -1,236,400,000 -1,148,600,000                   
      net increase /(decrease) in client funds obligations
    		                                 
      net proceeds/(payments) related to reverse repurchase agreements
    		             22,300,000                    
      cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of year
    		                                 
      cash, cash equivalents, restricted cash, and restricted cash equivalents, end of year
    		                                 
      increase in accrued expenses and other liabilities
    		                   114,300,000 105,600,000          110,300,000 -31,900,000 -163,200,000 
      impairment of assets
    		              12,300,000 2,600,000 2,200,000 2,800,000                
      gain on sale of assets
    		             -1,300,000 -6,400,000 -1,600,000 -1,600,000 -200,000      0          
      increase in accounts payable
    		                                 
      net cash flows from investing activities
    		                 264,200,000    -2,859,700,000 715,900,000  -4,314,000,000 5,882,100,000    -4,155,700,000    
      net (payments)/proceeds related to reverse repurchase agreements
    		                 -13,600,000                
      cash provided by:
    		                                 
      operating activities
    		                                 
      investing activities
    		                                 
      financing activities
    		                                 
      net pension expense
    		                   -3,000,000 10,900,000 10,900,000 10,900,000 9,200,000 9,100,000 9,200,000 10,400,000 10,100,000 10,100,000 10,100,000 8,700,000 8,700,000 8,300,000 
      impairment of intangible assets
    		                                 
      changes in operating assets and liabilities, net of effects from acquisitions:
    		                                 
      (decrease) / increase in accounts payable
    		                                 
      (decrease) / increase in accrued expenses and other liabilities
    		                                 
      net cash flows from / (used in) investing activities
    		                                 
      net payments of reverse repurchase agreements
    		                                 
      net cash flows (used in) / provided by financing activities
    		                                 
      gain on sale of divested businesses, net of tax
    		                                 
      changes in operating assets and liabilities, net of effects from acquisitions and divestitures of businesses:
    		                                 
      proceeds from the sale of divested businesses
    		                                 
      net proceeds from reverse repurchase agreements
    		                     -428,200,000 441,700,000           
      decrease/(increase) in other assets
    		                                 
      proceeds from debt issuance
    		                                 
      gain on sale of building
    		                              3,800,000   
      proceeds from the sale of notes receivable
    		                                 
      operating activities of discontinued operations
    		                   -1,200,000 0 1,300,000 100,000        0   
      net decrease/(increase) in restricted cash and cash equivalents held to satisfy client funds obligations
    		                                 
      dividend received from cdk global, inc.
    		                                 
      cash retained by cdk global, inc.
    		                                 
      investing activities of discontinued operations
    		                   100,000 0          0   
      net cash flows provided by/(used in) investing activities
    		                                 
      proceeds from stock purchase plan and exercises of stock options
    		                   29,800,000 59,800,000 49,300,000 80,200,000 72,100,000 69,300,000 48,900,000 132,700,000 216,900,000 106,800,000 21,800,000 39,800,000 7,600,000 -24,000,000 
      net repayments from issuance of commercial paper
    		                                 
      financing activities of discontinued operations
    		                                 
      effect of exchange rate changes on cash and cash equivalents
    		                   4,400,000 -12,600,000 4,400,000 11,800,000 10,000,000 -10,800,000 -23,500,000 5,400,000 13,400,000 -5,100,000 28,000,000 -15,600,000 35,400,000 1,800,000 
      net change in cash and cash equivalents
    		                   184,900,000 256,800,000 273,500,000 -430,700,000 333,800,000 82,400,000 -140,500,000 -211,500,000 295,200,000 129,000,000 -466,600,000 -321,700,000 901,900,000 58,500,000 
      cash and cash equivalents, beginning of period
    		                       0 0 1,389,400,000  0 0 1,643,300,000    
      cash and cash equivalents, end of period
    		                       333,800,000 82,400,000 1,248,900,000  295,200,000 129,000,000 1,176,700,000    
      excess tax benefit related to exercise of stock options and restricted stock
    		                                 
      net realized loss / (gain) from the sales of marketable securities
    		                                 
      net (increase) / decrease in restricted cash and cash equivalents held to satisfy client funds obligations
    		                                 
      net cash flows (used in) / provided by investing activities
    		                                 
      net increase / (decrease) in client funds obligations
    		                                 
      net repayments from reverse repurchase agreements
    		                                 
      net (repayments) / proceeds from issuance of commercial paper
    		                                 
      net cash flows from / (used in) financing activities
    		                                 
      less cash and cash equivalents of discontinued operations, end of period
    		                                 
      cash and cash equivalents of continuing operations, end of period
    		                   335,900,000 256,800,000 273,500,000 1,117,400,000           
      net realized gain from the sales of marketable securities
    		                   3,300,000 -6,000,000 -9,300,000 -4,500,000 -3,600,000 -8,200,000 -4,000,000    -11,800,000  -2,500,000 6,600,000 
      goodwill impairment
    		                                 
      gains on sales of buildings
    		                    0       0 0 -1,800,000    
      gain on sale of discontinued businesses, net of tax
    		                   26,200,000 0           -5,400,000 0 
      increase / (decrease) in accounts payable
    		                                 
      proceeds from the sale of businesses included in discontinued operations
    		                   -137,000,000 0          0   
      net (repayments of) / proceeds from reverse repurchase agreements
    		                                 
      net (repayments of) / proceeds from issuance of commercial paper
    		                                 
      impairment losses on available-for-sale securities
    		                       0       9,100,000   
      impairment losses on assets held for sale
    		                          3,100,000 0 0 8,600,000    
      changes in operating assets and liabilities, net of effects from acquisitions
    		                                 
      and divestitures of businesses:
    		                                 
      net decrease / (increase) in restricted cash and cash equivalents held to satisfy client funds obligations
    		                                 
      net (decrease) / increase in client funds obligations
    		                                 
      cash and cash equivalents of continuing operations, beginning of period
    		                   151,000,000 0 0 1,548,100,000          0 
      adjustments to reconcile net earnings to cash flows from operating activities
    		                                 
      changes in operating assets and liabilities, net of effects from acquisitions and divestiture of business:
    		                                 
      net increase in restricted cash and cash equivalents held to satisfy client funds obligations
    		                           -7,947,700,000 -1,064,100,000 -3,380,400,000    
      adjustments to reconcile net earnings to cash flows provided by
    		                                 
      operating activities:
    		                                 
      net (increase)/decrease in restricted cash and cash equivalents held to satisfy client funds obligations
    		                                 
      net cash flows (used in)/provided by operating activities
    		                      -65,100,000           
      net decrease in restricted cash and cash equivalents held to satisfy client funds obligations
    		                      943,600,000           
      proceeds from the sale of property, plant and equipment and other assets
    		                       0          
      net amortization of premiums and accretion of discounts
    		                                 
      on available-for-sale securities
    		                         12,800,000        
      changes in operating assets and liabilities, net of effects
    		                                 
      from acquisitions and divestitures of businesses:
    		                                 
      proceeds from the sales and maturities of corporate
    		                                 
      and client funds marketable securities
    		                         844,300,000        
      net decrease (increase) in restricted cash and cash equivalents
    		                                 
      held to satisfy client fund obligations
    		                         6,192,200,000        
      proceeds from the sale of property, plant and equipment
    		                          0 0 100,000 13,000,000 0 5,800,000 0 
      cash flows from operating activities
    		                                 
      excess tax benefit related to exercises of stock options
    		                                 
      net realized (gain) income from the sales of marketable securities
    		                                 
      gain on sales of buildings
    		                                 
      (increase) in accounts receivable
    		                                 
      cash flows from investing activities
    		                                 
      net increase in restricted cash and cash equivalents and other restricted assets held to satisfy client funds obligations
    		                               4,515,000,000 3,915,900,000 
      reclassification from cash and cash equivalents to short-term marketable securities
    		                               0 0 
      cash flows from financing activities
    		                                 
      proceeds from issuance of debt
    		                               0 0 
      net purchases of reverse repurchase agreements
    		                                0 
      net (repayment) proceeds of commercial paper borrowing
    		                                 
      cash and cash equivalents of continuing operations, beginning of year
    		                                 
      cash and cash equivalents of discontinued operations, beginning of year
    		                                 
      cash and cash equivalents, end of year
    		                                 
      less cash and cash equivalents of discontinued operations, end of year
    		                                 
      cash and cash equivalents of continuing operations, end of year
    		                                 
      net realized (gain)/income from the sales of marketable securities
    		                           -4,300,000      
      (increase)/decrease in other assets
    		                           -12,500,000      
      net repayment of commercial paper
    		                                 
      changes in operating assets and liabilities, net of effects from acquistions and divestitures of businesses:
    		                                 
      decrease (increase) in other assets
    		                              -125,100,000   
      net (purchases of) proceeds from reverse repurchase agreements
    		                                 
      net cash flows from (used in) financing activities
    		                                 
      net realized income from the sales of marketable securities
    		                                 
      (gain) loss on sale of discontinued businesses, net of tax
    		                                 
      net increase in restricted cash and cash equivalents and other restricted assets
    		                                 
      held to satisfy client funds obligations
    		                                 
      net repayment of commercial paper borrowing
    		                                 
      cash and cash equivalents of discontinued operations, beginning of period
    		                                 
      gain on sale of cost-based investment
    		                                 
      (increase) in other assets
    		                                 
      proceeds from the sale of cost-based investment
    		                                 
      dividend received from broadridge financial solutions, inc., net of 29.9 million in cash retained by broadridge financial solutions, inc.
    		                                 
      proceeds from the sale of businesses included in discontinued operations, net of cash divested
    		                                 
      gain on sale of assets held for sale
    		                                0 
      impairment of assets of discontinued operations businesses
    		                                 
      decrease (increase) in accounts receivable
    		                                 
      net decrease (increase) in restricted cash and cash equivalents and other restricted assets held to satisfy client funds obligations
    		                                 
      see notes to consolidated financial statements.
    		                                 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.